3.050USD-4.09%Mkt Cap: 24.30M USDP/E: —Last update: 2026-06-01
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States. The company's lead phospholipid d…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap24.30M USD
Enterprise Value20.18M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-21.79M USD
Revenue/Share—
Last Price3.050 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees11
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS15117F8077
Valuation
P/E (Trailing)—
P/E (Forward)-1.96
PEG—
EV/EBITDA-0.91
EV/Revenue—
P/S—
P/B4.73
EPS (TTM)-5.38
EPS (Forward)-1.60
52W Range
2.4303% of range20.70
52W High20.70 USD
52W Low2.430 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-255.25%
ROA-145.48%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.12M USD
CapEx (TTM)5.88K USD
FCF Margin—
FCF Yield-52.62%
Net Debt-6.82M USD
Net Debt/EBITDA0.31
Balance Sheet
Debt/Equity0.05
Current Ratio1.90
Quick Ratio1.71
Book Value/Sh0.6640 USD
Cash/Share1.044 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 17, 2018
Splits
Last Split1:30
Split DateJun 24, 2025
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)10.33 USD
Target Range10.00 USD – 11.00 USD
# Analysts3
Ownership
Shares Out.7.99M
Float7.83M
Insiders2.29%
Institutions4.17%
Short Interest
Short Ratio0.3d
Short % Float9.77%
Short % Out.9.73%
Shares Short777.62K
Short (prev mo.)27.20K
Technical
SMA 502.930 (+4.1%)
SMA 2003.624 (-15.8%)
Beta0.43
S&P 52W Chg27.94%
Avg Vol (30d)2.05M
Avg Vol (10d)250.12K
Technical Indicators
RSI (14)55.6
MACD0.0713
MACD Signal0.0678
MACD Hist.+0.0036
BB Upper3.460 USD
BB Middle3.111 USD
BB Lower2.762 USD
BB Width22.45%
ATR (14)0.2668 USD
Vol Ratio (20d)0.06x